Thus, we found that NF-κB activation directly precedes the transcriptional activation of Lcn2 and that of pro-inflammatory cytokines, suggesting that Lcn2 transcription is part of an UPR-mediated inflammatory program in prostate cancer cells. The gene discussed is LCN2; the disease is prostate cancer.